Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Postoperative Interferon-alpha Treatment in Patients Underwent Curative Surgery for Hepatocellular Carcinoma With a Low miR-26 Expression: a Multi-center Randomized Clinical Trial.

NCT01681446 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01681446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01681446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Postoperative Interferon-alpha Treatment in Patients Underwent Curative Surgery for Hepatocellular Carcinoma With a Low miR-26 Expression: a Multi-center Randomized Clinical Trial.
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2012
Completion date
August 31, 2019
Enrollment
296 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma